Stock Futures Slightly Lower Amid Oil Price Volatility
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 17 2026
0mins
Should l Buy HITI?
Stock futures were fractionally lower following marginal gains during Tuesday's session amid continuing conflict in Iran. Though oil ended up down for the session, it was trading higher earlier in the session once again following comments from President Trump on Monday, in which he suggested that a coalition to protect shipping along the Strait of Hormuz remains in the works, though he told reporters that some countries are "less than enthusiastic" about such plans. Meanwhile, investors continue to monitor further developments in Iran, particularly after Iran's security chief Ali Larijani was killed in airstrikes overnight, according to Israeli Defense Minister Israel Katz.Check out this evening's top movers from around Wall Street, compiled by The Fly.HIGHER AFTER EARNINGS -High Tideup 8.4%ALSO HIGHER -Swarmerup 35.2% after its IPO opened at $12.50 per shareLOWER AFTER EARNINGS -Cibusdown 10.3%Lululemondown 1.6%ALSO LOWER -Intelligent Protectiondown 8.5% after filing to sell 9M shares of common stock for holders
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HITI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HITI
Wall Street analysts forecast HITI stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 2.400
Low
7.50
Averages
7.50
High
7.50
Current: 2.400
Low
7.50
Averages
7.50
High
7.50
About HITI
High Tide Inc. is a retail-focused cannabis company. The Company’s segments include bricks-and-mortar, e-commerce and medical cannabis distribution. Its Bricks-and-mortar segment includes the Company’s Canadian bricks-and-mortar locations. Its E-commerce segment includes the Company’s United States and international subsidiaries and supports the distribution of accessories and other items to the United States. The medical cannabis distribution segment includes the medical cannabis distribution operations. It offers a suite of proprietary brands which include Dopezilla, Atomik, Puff Puff Pass, Vodka Glass, Queen of Bud, and Cabana Cannabis Co. Canna Cabana is the Company’s primary retail cannabis business, offering the retail sale of various cannabis products and accessories through its provincially authorized cannabis retail store locations. Canna Cabana operates a retail cannabis chain with approximately 219 branded stores operating across Canada.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
High Tide Addresses Unusual Trading Activity Concerns
- Unusual Trading Patterns: High Tide has consistently delivered financial results exceeding analyst expectations over the past ten quarters; however, it has observed a recurring trend where the closing price on the following trading day is lower, potentially undermining investor confidence.
- Investigation Measures: The company plans to retain qualified forensic investigators and industry specialists to conduct an independent review of trading activity, particularly focusing on transactions surrounding earnings releases, to ensure transparency and protect shareholder interests.
- Regulatory Cooperation: High Tide intends to submit the findings of the investigation along with supporting evidence to regulatory authorities in Canada and the United States, demonstrating the company's commitment to compliance and aiming to maintain market fairness and transparency.
- Shareholder Communication: The company encourages any shareholders or market participants with relevant information regarding unusual trading activity to contact them, ensuring that all received information will be treated with appropriate confidentiality, thereby enhancing shareholder trust.
See More
High Tide Opens New Store in Ontario on 4/20
- New Store Opening: High Tide's Canna Cabana retail store in Caledonia, Ontario, officially opens on April 20, 2026, bringing the total number of stores in Canada to 221, thereby reinforcing its market position.
- Strategic Location: The new store is strategically located at the south end of town, away from competitors, and surrounded by a pharmacy and liquor store, which is expected to attract adult consumers from Caledonia and Haldimand County, driving sales growth.
- Brand Development: Founder Raj Grover emphasized the symbolic significance of the opening date, aligning with the company's growth journey since 2018, showcasing High Tide's ongoing commitment to delivering exceptional customer experience and value.
- Market Share Expansion: As the second-largest retail brand globally, Canna Cabana holds a 12% market share in Canada, and the new store is anticipated to further enhance its competitiveness in the rapidly growing Canadian cannabis market.
See More
High Tide Opens New Canna Cabana Store in Ontario
- New Store Opening: High Tide opened a new Canna Cabana retail store in Caledonia, Ontario, on April 20, 2026, bringing its total store count to 221 across Canada, thereby reinforcing its market leadership.
- Market Positioning: The new location is strategically situated at the south end of Caledonia, away from competitors, and surrounded by a pharmacy and liquor store, targeting adult consumers from affluent households, which is expected to significantly enhance the company's market share in the region.
- Brand Development: Founder Raj Grover noted that the opening coincides with the eight-year anniversary of Canna Cabana, emphasizing the company's commitment to delivering an exceptional shopping experience, which will further enhance brand recognition and customer loyalty.
- Industry Recognition: High Tide has been named one of Canada's Top Growing Companies for five consecutive years and was recognized as one of the fastest-growing companies in the Americas by the Financial Times in 2023, showcasing its strong performance in the rapidly evolving cannabis market.
See More
High Tide to Participate in Multiple Conferences Across North America and Europe
- Market Share Growth: High Tide's Canna Cabana operates 220 domestic and 1 international store, capturing a 12% market share, establishing itself as the second-largest cannabis retail brand globally, showcasing its strong competitive position in a rapidly growing market.
- International Expansion: In 2025, High Tide became the first North American cannabis operator to establish a physical presence in Germany, further broadening its global business footprint and enhancing its influence in international markets.
- Industry Recognition: High Tide has been named one of Canada's Top Growing Companies by the Globe and Mail for five consecutive years and ranked first in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023, highlighting its leadership in the industry.
- Medical Cannabis Distribution: Its subsidiary Remexian Pharma GmbH holds extensive import licenses for medical cannabis in Germany, allowing imports from 19 countries, thereby solidifying its market position in the medical cannabis sector.
See More
High Tide Executives to Speak at Multiple Conferences
- Executive Conference Schedule: High Tide executives will speak at several cannabis and investment conferences across North America and Europe, including the International Cannabis Business Conference in Berlin on April 13, showcasing the company's leadership in the industry.
- Market Share Growth: Canna Cabana, as Canada's largest retail chain, operates 220 domestic and 1 international location, capturing a 12% market share, demonstrating the company's strong performance in the rapidly growing cannabis market.
- International Expansion Strategy: High Tide became the first North American cannabis operator to establish a physical presence in Germany in 2025, further solidifying its global market position and laying the groundwork for future international expansion.
- Industry Recognition: High Tide has been named one of Canada's Top Growing Companies by the Globe and Mail for five consecutive years and ranked as one of the fastest-growing companies in the Americas by the Financial Times in 2023, highlighting its competitive edge and market influence.
See More
NuLeaf Naturals Joins CMS Innovation Center's BEI Pilot Program
- CMS Program Participation: NuLeaf Naturals intends to participate in the U.S. CMS Innovation Center's Beneficiary Engagement Incentive program as a supplier of eligible CBD products, marking a significant step toward integrating CBD into healthcare models.
- Product Compliance: NuLeaf's product portfolio includes THC-free and broad-spectrum CBD formats designed to meet the program's compliance requirements, thereby enhancing its competitive position in the market.
- Market Potential: The CMS program allows participating organizations to provide eligible CBD products to Medicare beneficiaries at no cost, up to $500 per beneficiary, which is expected to create significant market opportunities for NuLeaf and drive growth in its U.S. CBD business.
- Strategic Collaboration: NuLeaf's founding membership in the National Compassionate Care Council further solidifies its strategic position in advancing evidence-based cannabinoid policy and improving patient access to cannabinoid therapies.
See More
High Tide Addresses Unusual Trading Activity Concerns
- Unusual Trading Patterns: High Tide has consistently delivered financial results exceeding analyst expectations over the past ten quarters; however, it has observed a recurring trend where the closing price on the following trading day is lower, potentially undermining investor confidence.
- Investigation Measures: The company plans to retain qualified forensic investigators and industry specialists to conduct an independent review of trading activity, particularly focusing on transactions surrounding earnings releases, to ensure transparency and protect shareholder interests.
- Regulatory Cooperation: High Tide intends to submit the findings of the investigation along with supporting evidence to regulatory authorities in Canada and the United States, demonstrating the company's commitment to compliance and aiming to maintain market fairness and transparency.
- Shareholder Communication: The company encourages any shareholders or market participants with relevant information regarding unusual trading activity to contact them, ensuring that all received information will be treated with appropriate confidentiality, thereby enhancing shareholder trust.
See More
High Tide Opens New Store in Ontario on 4/20
- New Store Opening: High Tide's Canna Cabana retail store in Caledonia, Ontario, officially opens on April 20, 2026, bringing the total number of stores in Canada to 221, thereby reinforcing its market position.
- Strategic Location: The new store is strategically located at the south end of town, away from competitors, and surrounded by a pharmacy and liquor store, which is expected to attract adult consumers from Caledonia and Haldimand County, driving sales growth.
- Brand Development: Founder Raj Grover emphasized the symbolic significance of the opening date, aligning with the company's growth journey since 2018, showcasing High Tide's ongoing commitment to delivering exceptional customer experience and value.
- Market Share Expansion: As the second-largest retail brand globally, Canna Cabana holds a 12% market share in Canada, and the new store is anticipated to further enhance its competitiveness in the rapidly growing Canadian cannabis market.
See More
High Tide Opens New Canna Cabana Store in Ontario
- New Store Opening: High Tide opened a new Canna Cabana retail store in Caledonia, Ontario, on April 20, 2026, bringing its total store count to 221 across Canada, thereby reinforcing its market leadership.
- Market Positioning: The new location is strategically situated at the south end of Caledonia, away from competitors, and surrounded by a pharmacy and liquor store, targeting adult consumers from affluent households, which is expected to significantly enhance the company's market share in the region.
- Brand Development: Founder Raj Grover noted that the opening coincides with the eight-year anniversary of Canna Cabana, emphasizing the company's commitment to delivering an exceptional shopping experience, which will further enhance brand recognition and customer loyalty.
- Industry Recognition: High Tide has been named one of Canada's Top Growing Companies for five consecutive years and was recognized as one of the fastest-growing companies in the Americas by the Financial Times in 2023, showcasing its strong performance in the rapidly evolving cannabis market.
See More
High Tide to Participate in Multiple Conferences Across North America and Europe
- Market Share Growth: High Tide's Canna Cabana operates 220 domestic and 1 international store, capturing a 12% market share, establishing itself as the second-largest cannabis retail brand globally, showcasing its strong competitive position in a rapidly growing market.
- International Expansion: In 2025, High Tide became the first North American cannabis operator to establish a physical presence in Germany, further broadening its global business footprint and enhancing its influence in international markets.
- Industry Recognition: High Tide has been named one of Canada's Top Growing Companies by the Globe and Mail for five consecutive years and ranked first in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023, highlighting its leadership in the industry.
- Medical Cannabis Distribution: Its subsidiary Remexian Pharma GmbH holds extensive import licenses for medical cannabis in Germany, allowing imports from 19 countries, thereby solidifying its market position in the medical cannabis sector.
See More
High Tide Executives to Speak at Multiple Conferences
- Executive Conference Schedule: High Tide executives will speak at several cannabis and investment conferences across North America and Europe, including the International Cannabis Business Conference in Berlin on April 13, showcasing the company's leadership in the industry.
- Market Share Growth: Canna Cabana, as Canada's largest retail chain, operates 220 domestic and 1 international location, capturing a 12% market share, demonstrating the company's strong performance in the rapidly growing cannabis market.
- International Expansion Strategy: High Tide became the first North American cannabis operator to establish a physical presence in Germany in 2025, further solidifying its global market position and laying the groundwork for future international expansion.
- Industry Recognition: High Tide has been named one of Canada's Top Growing Companies by the Globe and Mail for five consecutive years and ranked as one of the fastest-growing companies in the Americas by the Financial Times in 2023, highlighting its competitive edge and market influence.
See More
NuLeaf Naturals Joins CMS Innovation Center's BEI Pilot Program
- CMS Program Participation: NuLeaf Naturals intends to participate in the U.S. CMS Innovation Center's Beneficiary Engagement Incentive program as a supplier of eligible CBD products, marking a significant step toward integrating CBD into healthcare models.
- Product Compliance: NuLeaf's product portfolio includes THC-free and broad-spectrum CBD formats designed to meet the program's compliance requirements, thereby enhancing its competitive position in the market.
- Market Potential: The CMS program allows participating organizations to provide eligible CBD products to Medicare beneficiaries at no cost, up to $500 per beneficiary, which is expected to create significant market opportunities for NuLeaf and drive growth in its U.S. CBD business.
- Strategic Collaboration: NuLeaf's founding membership in the National Compassionate Care Council further solidifies its strategic position in advancing evidence-based cannabinoid policy and improving patient access to cannabinoid therapies.
See More
